Ursosan capsules 250 mg 50 pcs.

Active ingredient: ursodeoxycholic acid;

1 capsule contains 250 mg of ursodeoxycholic acid;

Excipients: corn starch, corn starch, colloidal silicon dioxide, magnesium stearate;

Ingredients: gelatin, titanium dioxide (E 171).

• hypersensitivity to any substance included in the composition of the medicinal product;
• acute inflammation of the gallbladder or bile ducts;
• bile duct obstruction (blockage of the common bile duct or duct);
• frequent episodes of hepatic colic;
• radiopaque calcified gallstones;
• gallbladder contractility disorders;
• late stages of primary biliary cirrhosis due to insufficient therapeutic effect;
• Use in children: unsuccessful outcome of portoenterostomy or lack of adequate bile outflow in children with biliary atresia.

For patients whose body weight is less than 47 kg or who have difficulty swallowing capsules, it is recommended to use ursodeoxycholic acid in a different dosage form.

One capsule of Ursosan 250 mg is taken once a day with some liquid in the evening before bedtime.

Usually, for the treatment of gastritis with bile reflux, Ursosan 250 mg capsules are taken for 10-14 days. The duration of treatment depends on the patient’s condition. The doctor should decide on the duration of treatment in each case individually.

Pregnant women

Ursosan 250 mg capsules should not be used during pregnancy unless clearly necessary. Women of childbearing age should only take the drug if they are using reliable contraception.

Children

Apply to children aged 6 to 18 years.

Drivers

No effect on the ability to drive or use other mechanisms was observed.

In cases of overdose, diarrhea may occur. In general, other symptoms of overdose are unlikely, since the absorption of ursodeoxycholic acid decreases with increasing dose and therefore most of it is excreted in the feces.

If diarrhea occurs, the dose should be reduced, and if diarrhea is persistent, therapy should be discontinued.

No specific measures are required. The consequences of diarrhea should be treated symptomatically with restoration of fluid and electrolyte balance.

Gastrointestinal: In clinical studies, there were frequent (> 1/100 and <1/10) reports of pasty stools or diarrhea during treatment with ursodeoxycholic acid.

Extragenic hormones, as well as drugs to reduce the concentration of cholesterol in the blood, can increase the secretion of cholesterol by the liver, and thus contribute to the formation of stones in the gallbladder, which is the opposite effect of ursodeoxycholic acid, which is used to dissolve them.

Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children.

Shelf life – 4 years.